As a European developer of technology; it’s clear that the US is our key market; how do we penetrate the largest healthcare market in the world?

The US is the largest healthcare market in the world, and an enormous consumer of new health and wellness products and services. Despite its stringent regulatory and healthcare economics environment, the size of the market opportunity is of a scale that few international developers of new healthcare technologies can ignore the US market as a key strategic target. Geographical separation and lack of familiarity with the US regulatory, reimbursement processes, along with a lack of access to corporate development resources to forge corporate alliances and distribution partnerships, however, could pose significant challenges to international companies.

SI has been approached by multiple European and Australian companies that used SI as a “one stop shop” for expertise in strategy, market research, technology assessment, the FDA regulatory process, the all important reimbursement process, and business development expertise to establish relevant corporate partnerships for penetrating the US healthcare market. Most such engagements have led to continued involvement of SI with the client company through multiple generations of existing products, and also the introduction of new products into the US marketplace.